Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Leukemia, Prolymphocytic, B-Cell

Known as: Leukemia, B-Cell Prolymphocytic, B-Cell Prolymphocytic Leukemia, B-Cell Prolymphocytic Leukemias 
A malignant B-cell lymphoproliferative process affecting the blood, bone marrow, and spleen. The B-prolymphocytes are medium-sized, round lymphoid… Expand
National Institutes of Health

Related topics

Related topics

24 relations
AnemiaAtypical lymphocyteB lymphoblastB-Lymphocytes
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.
Disease progression in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib has been attributed to histologic… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2008
Review
2008
Prolymphocytic leukaemia of B‐ and T‐cell subtype: a state‐of‐the‐art paper
Prolymphocytic leukaemias of B and T cell subtype are rare diseases. Despite recent advances in immunophenotyping and molecular… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Deregulated expression of TCL1 causes T cell leukemia in mice.
The TCL1 oncogene on human chromosome 14q32.1 is involved in the development of T cell leukemia in humans. These leukemias are… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Subcutaneous CAMPATH‐1H in fludarabine‐resistant/relapsed chronic lymphocytic and B‐prolymphocytic leukaemia
Seven patients with B‐cell leukaemia — six with chronic lymphocytic leukaemia (CLL) and one with B‐prolymphocytic leukaemia (B… Expand
Is this relevant?
Review
1997
Review
1997
Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.
Fludarabine is an antineoplastic agent which has been studied in patients with a variety of lymphoproliferative malignancies… Expand
  • figure 1
  • table I
  • table II
  • table III
  • figure 2
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Atypical chronic lymphocytic leukaemia witht(ll;14)(ql3;q32): karyotype evolution and prolymphocytic transformation
Summary. In order to define better the cytological and clinical features of atypical B‐cell chronic lymphocytic leukaemia (B‐CLL… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
BCL2 translocations in leukemias of mature B cells.
Although translocations of the BCL2 gene are frequent in B-cell non-Hodgkin's lymphomas (B-NHL) the incidence, nature, and… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1994
Highly Cited
1994
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias.
BACKGROUND 2-chlorodeoxyadenosine (2-CDA) is a new purine analogue which has been shown to be highly active in… Expand
Is this relevant?
Highly Cited
1986
Highly Cited
1986
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia
Summary. The clinical and laboratory features of 300 patients with chronic lymphocytic leukaemia (CLL) and prolymphocytic… Expand
Is this relevant?
Highly Cited
1984
Highly Cited
1984
Leukemia
  • C. Geary
  • British Journal of Cancer
  • 1984
    • Corpus ID: 215711124
Your friend is lucky to have someone like you who wants to learn more about what they’re going through. Leukemia is a general… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE